Publication | Closed Access
Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury
181
Citations
18
References
2003
Year
There are concerns that infusion of certain hydroxyethyl starch (HES) types for plasma volume expansion may influence coagulation and renal function. We investigated the safety of the novel HES 130/0.4 in patients with severe cranio-cerebral trauma. The repetitive HES doses administered in this study are the largest reported in the literature.
| Year | Citations | |
|---|---|---|
1993 | 2.2K | |
1991 | 815 | |
2001 | 743 | |
1996 | 466 | |
2001 | 251 | |
2001 | 230 | |
2001 | 229 | |
2000 | 195 | |
2002 | 149 | |
2002 | 130 |
Page 1
Page 1